SRR12696770
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- E2F_TARGETS+0.200
- G2M_CHECKPOINT+0.200
- MITOTIC_SPINDLE+0.200
- SPERMATOGENESIS+0.200
- KRAS_SIGNALING_DN+0.100
- PANCREAS_BETA_CELLS+0.100
- APICAL_JUNCTION+0.000
- BILE_ACID_METABOLISM+0.000
- COAGULATION+0.000
- DNA_REPAIR+0.000
Top 10 suppressed
- ALLOGRAFT_REJECTION-0.500
- IL6_JAK_STAT3_SIGNALING-0.500
- INFLAMMATORY_RESPONSE-0.400
- INTERFERON_ALPHA_RESPONSE-0.400
- INTERFERON_GAMMA_RESPONSE-0.400
- OXIDATIVE_PHOSPHORYLATION-0.400
- PI3K_AKT_MTOR_SIGNALING-0.400
- COMPLEMENT-0.300
- IL2_STAT5_SIGNALING-0.300
- MYC_TARGETS_V1-0.300
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
5 twins match this tumor's tissue · 5 come from a different tissue of origin ← cross-tissue dominant
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR13780248 | — | cohortSC | 0.874 |
| 2 | BS_4E1G7E3G | ATRT | — | 0.865 |
| 3 | BS_4W68NV3M | medulloblastoma | — | 0.862 |
| 4 | 266352 | EPN | EPN Tumor | 0.860 |
| 5 | SRR23303774 | — | — | 0.859 |
| 6 | BS_S1M423AB | Embryonal tumors | — | 0.854 |
| 7 | SRR8518343 | — | E | 0.852 |
| 8 | SRR22247242 | — | cohortSC | 0.851 |
| 9 | BS_W311713R | medulloblastoma | — | 0.848 |
| 10 | SRR6013518 | — | cohortSQ1 | 0.847 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 6 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.200 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.200 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.200 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.200 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.100 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.100 | Cobimetinib | — uncovered |